Loading
companiesCompany
Takara Bio
Takara Bio is a Japanese life-science tools company that also develops gene and cell therapies for cancer, including an oncolytic herpes virus and engineered T cells, and manufactures viral vectors for others.
Also called: Takara Bio Inc.タカラバイオ
Overview
Takara Bio Inc., founded in 2002 and based in Kusatsu, Shiga, sells research reagents and contract manufactures viral vectors and cell therapies. Its own pipeline includes the oncolytic herpes simplex virus canerpaturev (C-REV), tested in phase 2 and 3 in pancreatic cancer and melanoma, and TCR- and CAR-engineered T cells developed with Japanese academic groups. Its trials are registered on ClinicalTrials.gov under Takara Bio as lead sponsor.
Headquarters
Kusatsu, JP
Scorecard
All companies#357of 1244 companies, score 11
- phase 3 +3
- phase 1/2 +1
- targets +2
- modalities +2
- registry trials +3
0 approved, 1 in phase 3, 1 earlier, 1 targets, 3 registry studies. Formula on the scorecards page.
Type
Stage
Public
Website
Founded
2002
Phase 3TCR-T cell therapy (per the sponsor's pipeline page; form not stated in the registry record)
TBI-1301 is an experimental investigational agent whose form is not stated in the registry from Takara Bio in phase 3 trials for sarcomas, with its target not yet stated publicly.
Phase 2CAR-T cell therapy
TBI-1501 is an experimental CAR-T cell therapy from Takara Bio in phase 2 trials for acute lymphoblastic leukaemia, aimed at CD19.
Similar pages
- CompanyMedigene
Shares TCR-T cell therapy, Pivotal (registrational) trial, Clinical trial, Pancreatic ductal adenocarcinoma.
- CompanyLisata Therapeutics
Shares Pivotal (registrational) trial, Clinical trial, Pancreatic ductal adenocarcinoma.
- CompanyHiberCell
Shares Pivotal (registrational) trial, Clinical trial, Melanoma.
- CompanyIdera Pharmaceuticals
Shares Pivotal (registrational) trial, Clinical trial, Melanoma.
- CompanyMerrimack Pharmaceuticals
Shares Pivotal (registrational) trial, Clinical trial, Pancreatic ductal adenocarcinoma.
- CompanySorrento Therapeutics
Shares Pivotal (registrational) trial, Clinical trial, Pancreatic ductal adenocarcinoma.
- CompanyCEBIOTEX
Shares Pivotal (registrational) trial, Clinical trial, Pancreatic ductal adenocarcinoma.
- CompanyGeorgiamune
Shares Pivotal (registrational) trial, Clinical trial, Melanoma.